Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 6:07 pm Purchase | 2025-03-31 | 13G | Universe Pharmaceuticals INC UPC | Anson Funds Management LP | 234,374 1.000% | 214,816 (+1098.34%) | Filing History |
| 2025-05-15 5:23 pm Purchase | 2025-03-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Anson Funds Management LP | 595,719 9.900% | 595,538 (+328311.63%) | Filing History |
| 2025-05-15 5:15 pm Purchase | 2025-03-31 | 13G | NRx Pharmaceuticals, Inc. NRXP | Anson Funds Management LP | 1,179,061 7.000% | 1,179,061 (New Position) | Filing History |
| 2025-05-15 5:14 pm Purchase | 2025-03-31 | 13G | Applied DNA Sciences, Inc. APDN | Anson Funds Management LP | 209,469 5.400% | 207,945 (+13643.42%) | Filing History |
| 2025-05-15 5:05 pm Sale | 2025-03-31 | 13G | SRM Entertainment, Inc. SRM | Anson Funds Management LP | 0 0.000% | -1,395,235 (Position Closed) | Filing History |
| 2025-05-15 5:03 pm Purchase | 2025-03-31 | 13G | Sharps Technology, Inc. STSS | Anson Funds Management LP | 1,800,000 9.900% | 1,800,000 (New Position) | Filing History |
| 2025-05-15 4:59 pm Purchase | 2025-03-31 | 13G | SELLAS Life Sciences Group, Inc. SLS | Anson Funds Management LP | 7,579,095 8.300% | 7,579,095 (New Position) | Filing History |
| 2025-05-15 4:57 pm Purchase | 2025-03-31 | 13G | Femto Technologies Inc. FMTO | Anson Funds Management LP | 324,808 9.900% | 324,808 (New Position) | Filing History |
| 2025-05-15 4:56 pm Purchase | 2025-03-31 | 13G | Color Star Technology Co., Ltd. ADD | Anson Funds Management LP | 5,639,090 9.900% | 5,639,090 (New Position) | Filing History |
| 2025-05-15 4:34 pm Purchase | 2025-03-31 | 13G | Cyngn Inc. CYN | Anson Funds Management LP | 77,639 4.200% | 62,837 (+424.53%) | Filing History |
| 2025-05-15 4:32 pm Purchase | 2025-03-31 | 13G | Greenwave Technology Solutions, Inc. GWAV | Anson Funds Management LP | 4,843,160 8.000% | 3,810,748 (+369.11%) | Filing History |
| 2025-05-15 4:21 pm Purchase | 2025-03-31 | 13G | 180 Life Sciences Corp. ATNF | Anson Funds Management LP | 245,750 4.500% | 20,479 (+9.09%) | Filing History |
| 2025-05-15 4:12 pm Sale | 2025-03-31 | 13G | 22nd Century Group, Inc. XXII | Anson Funds Management LP | 176,094 7.400% | -2,256,126 (-92.76%) | Filing History |
| 2025-05-15 3:17 pm Purchase | 2025-03-31 | 13G | Datavault AI Inc. DVLT | Anson Funds Management LP | 3,214,941 4.900% | 2,861,820 (+810.44%) | Filing History |
| 2025-04-14 08:30 am Purchase | 2025-04-10 | 13D | The Lovesac Company LOVE | Anson Funds Management LP | 1,045,665 7.100% | 113,404 (+12.16%) | Filing History |
| 2025-03-25 11:45 am Purchase | 2025-03-13 | 13D | The Lovesac Company LOVE | Anson Funds Management LP | 932,261 6.000% | 117,898 (+14.48%) | Filing History |
| 2025-02-14 7:10 pm Purchase | 2024-12-31 | 13G | PMGC Holdings Inc. ELAB | Anson Funds Management LP | 151,501 4.900% | 149,900 (+9364.25%) | Filing History |
| 2025-02-14 6:36 pm Purchase | 2024-12-31 | 13G | 180 Life Sciences Corp. ATNF | Anson Funds Management LP | 225,271 7.100% | 225,271 (New Position) | Filing History |
| 2025-02-14 6:32 pm Unchanged | 2024-12-31 | 13G | Cyngn Inc. CYN | Anson Funds Management LP | 14,802 9.900% | 0 (Unchanged) | Filing History |
| 2025-02-14 6:30 pm Purchase | 2024-12-31 | 13G | Oncolytics Biotech Inc. ONCY | Anson Funds Management LP | 8,185,743 9.600% | 8,185,743 (New Position) | Filing History |